InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-11-21 | Dwight Evans(D-PA03) | house | Sale | $1,001 - $15,000 |
| 2025-10-31 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-09-23 | Valerie Hoyle(D-OR04) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Premiums | $134.75B+9.6% | $122.90B+23.9% | $99.19B+16.2% | $85.33B+12.1% | $76.13B |
| Net investment income | $2.23B+3.7% | $2.15B+86.7% | $1.15B+37.6% | $838.0M-30.1% | $1.20B |
| Total revenues | $402.07B+7.8% | $372.81B+4.2% | $357.78B+10.9% | $322.47B+10.4% | $292.11B |
| Cost of products sold | $221.17B+7.2% | $206.29B-5.0% | $217.10B+10.3% | $196.89B+12.0% | $175.80B |
| Health care costs | $125.54B+9.0% | $115.12B+33.5% | $86.25B+21.3% | $71.07B+10.7% | $64.19B |
| Operating expenses | $44.98B+7.8% | $41.71B+4.7% | $39.83B+4.2% | $38.21B+3.2% | $37.02B |
| Goodwill impairment | $5.72B | $0 | $0 | — | $431.0M |
| Restructuring charges | $0-100.0% | $1.18B+132.5% | $507.0M | $0 | $0 |
| Loss on assets held for sale | $0 | $0-100.0% | $349.0M-86.2% | $2.53B | $0 |
| Total operating costs | $397.41B+9.1% | $364.29B+5.9% | $344.03B+9.4% | $314.51B+12.8% | $278.80B |
| Operating income | $4.66B-45.3% | $8.52B-38.0% | $13.74B+72.8% | $7.95B-40.2% | $13.31B |
| Interest expense | -$3.12B-5.4% | -$2.96B-11.3% | -$2.66B-216.2% | $2.29B-8.6% | $2.50B |
| Gain on early extinguishment of debt | $0-100.0% | $491.0M | $0 | $0 | — |
| Gain on deconsolidation of subsidiary | $483.0M | $0 | $0 | — | — |
| Other income | $112.0M+13.1% | $99.0M+12.5% | $88.0M+152.1% | -$169.0M+7.1% | -$182.0M |
| Income before income tax provision | $2.14B-65.3% | $6.15B-45.0% | $11.17B+91.4% | $5.84B-44.6% | $10.54B |
| Income tax provision | $408.0M-73.9% | $1.56B-44.3% | $2.81B+85.9% | $1.51B-40.8% | $2.55B |
| Net income | $1.73B-62.3% | $4.59B-45.2% | $8.37B+93.4% | $4.33B-45.8% | $7.99B |
| Net (income) loss attributable to noncontrolling interests | $40.0M+42.9% | $28.0M+216.7% | -$24.0M-50.0% | -$16.0M-233.3% | $12.0M |
| Net income attributable to CVS Health | $1.77B-61.7% | $4.61B-44.7% | $8.34B+93.6% | $4.31B-46.1% | $8.00B |
| Basic (in dollars per share) | $1.4M-61.9% | $3.7M-43.5% | $6.5M+97.3% | $3.3M-45.8% | $6.1M |
| Diluted (in dollars per share) | $1.4M-62.0% | $3.7M-43.4% | $6.5M+98.5% | $3.3M-45.8% | $6.0M |
| Basic (in shares) | $1.27B+0.6% | $1.26B-2.0% | $1.28B-2.1% | $1.31B-0.5% | $1.32B |
| Diluted (in shares) | $1.27B+0.7% | $1.26B-2.2% | $1.29B-2.5% | $1.32B-0.5% | $1.33B |
| Products | |||||
| Revenues | $15.18B-6.6% | $16.24B+32.1% | $12.29B+27.0% | $9.68B-12.3% | $11.04B |
| Services | |||||
| Revenues | $15.18B-6.6% | $16.24B+32.1% | $12.29B+27.0% | $9.68B-12.3% | $11.04B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Jim Cramer Says “I Think That CVS Will Give You a Good Quarter”
Fathom Secures Strategic Investment From CVS Health Ventures to Accelerate Enterprise-Wide Autonomous Coding
Notable healthcare headlines for the week: Merck, Eli Lilly, and GE HealthCare in focus
Drugmakers petition Supreme Court to restore mifepristone mail-order access